Tomasz Cierpicki
- University of Michigan · Pathology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #16,504
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9339278Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0003-2058-0658Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
NIH Funding · FY2026
Linked Award Amount
$1.2M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#16,504
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Tomasz Cierpicki as a PI. Multi-PI records show the full award amount for context.
- 5R01CA282082-04R01Contact PITargeting PRC1 in leukemiaUniversity of Michigan · Pathology (NIH department code)$625Kaward amount
- 5R01CA285304-03R01Contact PIDevelopment of chemical probe targeting NSD3 SET domain in breast cancerUniversity of Michigan · Pathology (NIH department code)$572.3Kaward amount
Award organization
Organizations that administered FY2026 awards listing Tomasz Cierpicki as a PI.
FY2026 award administered by University of Michigan (MI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Michigan
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder